# Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

> **NCT05465655** · NA · TERMINATED · sponsor: **Cara Medical Ltd** · enrollment: 33 (actual)

## Conditions studied

- Transcatheter Aortic Valve Replacement

## Interventions

- **OTHER:** ECG monitoring for Conduction Disturbances

## Key facts

- **NCT ID:** NCT05465655
- **Lead sponsor:** Cara Medical Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-09
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Slow recruitment rate
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465655, "Cara CDRM (Conduction Disturbance Risk Monitor) 2.0". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05465655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*